AXIOMPHARMACEUTICALS
Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

Tissue repair & recovery

Wolverine Stack (BPC-157/TB-500 combination)

BPC-157 + TB-500 · Tissue Repair & Recovery Protocol

Research use onlyGBP reference pricing where listedUK dispatch on catalogue items

Overview

Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.

BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic of fibroblast and immune cell movement to injury sites.

Both peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.

BPC-157 demonstrates muscle regeneration; TB-500 promotes cell migration essential for repair.

Lee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4 combination.

Mechanism

Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.

BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic of fibroblast and immune cell movement to injury sites.

Both peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.

Research areas

  • Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.
  • BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic of fibroblast and immune cell movement to injury sites.
  • Both peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.
  • BPC-157 demonstrates muscle regeneration; TB-500 promotes cell migration essential for repair.
  • Lee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4 combination.

Research notes

  • Not extensively documented in human studies
  • Generally well-tolerated in available research
  • Any unusual lumps, growths, or rapid tissue changes
  • Severe injection site reactions or infections
  • Signs of allergic reaction (rash, swelling, difficulty breathing)

References

Questions

Should Wolverine Stack be injected at the injury site or systemically?

Both work, but local injection near injury sites concentrates effects and may accelerate healing faster. For joint injuries, intra-articular injection (like the Lee & Padgett study) may be to systemic SubQ injection. Systemic SubQ administration is more practical for non-accessible injuries and provides whole-body…

Can Wolverine Stack be used with growth hormone secretagogues like CJC-1295?

Yes, GH secretagogues (CJC-1295, Ipamorelin) complement Wolverine Stack synergistically. BPC-157 upregulates GH receptors while TB-500 regeneration - adding endogenous GH amplifies tissue repair effects. This combination is particularly valuable for athletic recovery and serious injury rehabilitation.